AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets

Pharmaceutical giant AbbVie (ABBV.N) has sued cancer treatment maker BeiGene (6160.HK) in Chicago federal court, accusing it of stealing trade secrets to develop a competing cancer-fighting therapy after hiring away a former longtime senior AbbVie scientist.